1-15 of 15
Keywords: Acid-labile subunit
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Horm Res Paediatr (2019) 92 (1): 15–27.
Published Online: 11 September 2019
..., and the increased expression of IGF-binding proteins (IGFBP)-1 and IGFBP-2, which inhibit IGF-I, in the placenta of SGA neonates. These observations suggest a decreased bioactivity of IGF-I in utero. IGF-I levels remain reduced in SGA children with short stature, as well as IGFBP-3 and acid-labile subunit levels...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Hormone Research (1994) 42 (4-5): 140–144.
Published Online: 05 December 2008
...Robert C. Baxter The actions and bioavailability of the insulin-like growth factors (IGFs) are regulated by a family of six IGF binding proteins. IGFBP-3, the major circulating IGFBP, is unique in combining with a glycoprotein, the acid-labile subunit (ALS), to form a ternary complex with IGF-I...
Journal Articles
Journal Articles
Hormone Research (2004) 62 (Suppl. 1): 44–49.
Published Online: 10 March 2005
...Catherine A. Lissett; Helena Gleeson; Stephen M. Shalet The insulin-like growth factor I (IGF-I) generation test has the potential to assess the ability of an individual to respond to an acute bolus of growth hormone (GH), in terms of IGF-I, IGF-binding protein 3 and acid-labile subunit responses...
Journal Articles
Hormone Research (2001) 55 (Suppl. 2): 100–105.
Published Online: 17 November 2004
... than other possible markers, such as IGF-binding protein 3 (IGFBP-3) and the acid-labile subunit (ALS). Accurate age-matched normative data are essential to give patient data diagnostic meaning. Such data are assay specific and must exclude those individuals with certain confounding medical conditions...
Journal Articles
Hormone Research (2004) 61 (2): 98–102.
Published Online: 02 March 2004
... dosage during the 2nd year of therapy as compared with group A (p < 0.02). Significant increases in insulin-like growth factor I (p < 0.0001), acid-labile subunit (p < 0.0002), and bone/chronological age ratio (p < 0.0001) were found after the 1st year of GH therapy, but no significant...
Journal Articles